Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
about
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementCannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.Potential effects of cannabidiol as a wake-promoting agent.Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytesRole of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiolTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.Blurred boundaries: the therapeutics and politics of medical marijuana.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsNeuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brainPsychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.Cannabidiol changes P-gp and BCRP expression in trophoblast cell linesMarijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Cannabidiol Does Not Dampen Responses to Emotional Stimuli in Healthy Adults.The potential role of cannabinoids in epilepsy treatment.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.Synthesis of (-)-Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)-Catalyzed Cycloisomerization.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells.Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury.Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure.Would some cannabinoids ameliorate symptoms of autism?Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.
P2860
Q21129107-47A3F595-F962-4CA5-81E6-3C03D796F07EQ28394506-20284444-CF3B-4DF0-9926-C692FE3CAB96Q30493082-F14C9B25-3DA7-49FF-80DB-15606A0D93C1Q33621686-0E8088B3-1FB0-4AFD-A502-7EA6D2C3D36CQ33664684-211BA4E8-4461-4150-85FA-06B7E591FF26Q33861917-9CE61325-5CCD-4DEB-94D3-FD1BAC1BBA6FQ33869556-5F0C70F7-9456-44FD-974B-55118A25C454Q33897251-97EBEBB1-05AD-438B-8A40-D01AE91FEACDQ34251969-0914DE54-E68E-405D-B36C-02503D0674B6Q34700334-13765C60-FBA5-43B0-80B9-9C95B29394B8Q34954213-84237208-8238-4E9B-9942-2E8E3334735DQ35000758-6F3FACF5-970E-42CD-A783-C58754B81A7EQ37178591-98FD20A6-2559-43B5-870A-9C037E2C02E3Q37512670-02CD44B8-4C99-4E6C-9EE0-A1954DC0F605Q37997020-34A38560-755F-4685-A05F-FEA230F5A32DQ38598495-2BB71D21-9DCA-485B-8E35-EAA62FFF4E02Q38606080-3ACDA046-FF52-4912-AC2D-9047F6223715Q38684679-8974F91F-31C8-44F5-8E23-7E143E9F6D89Q39360618-42699488-3FBC-4478-A129-73825A5407A0Q41350151-F8D6AAC0-1DF8-41B0-96E2-686697FE200EQ46293996-608C60AC-BA58-4EF7-819E-9D712C71D1F1Q47143965-9B103E12-65CE-4AFC-865A-720E1FBBE419Q48900936-7FC3178A-3430-4DC2-BD7B-D3C384553E2AQ49034782-60B71EC3-67F2-4CBE-8386-F4FEDF0A0037Q50341251-EFC200E6-782D-4AF7-926B-4ECCC1EF5041Q50995074-F8368194-212F-4B44-8FEB-01C942D742EFQ51316104-2D7D82EE-3E2B-40DF-9222-3B5AB10C7A58Q53403696-716792E0-4458-4AB9-89DE-190BA28489B0
P2860
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@ast
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@en
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@nl
type
label
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@ast
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@en
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@nl
prefLabel
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@ast
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@en
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@nl
P2093
P2860
P50
P356
P1476
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
@en
P2093
Angelo Blasio
Daniele De Filippis
Teresa Iuvone
P2860
P304
P356
10.1002/PTR.2625
P577
2009-05-01T00:00:00Z